Ticker Details
Celcuity Inc. Common Stock Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.
IPO Date:	September 20, 2017
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$4.68B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.77 | 3.28%
Avg Daily Range (30 D):	$2.11 | 2.36%
Avg Daily Range (90 D):	$3.36 | 3.12%

Institutional Daily Volume
Avg Daily Volume:	.19M
Avg Daily Volume (30 D):	.7M
Avg Daily Volume (90 D):	1.15M

Trade Size
Avg Trade Size (Sh.):	62
Avg Trade Size (Sh.) (30 D):	49
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	1,572
Avg Institutional Trade:	$4.59M
Avg Institutional Trade (30 D):	$5.23M
Avg Institutional Trade (90 D):	$5.26M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$9M
Avg Closing Trade (30 D):	$10.97M
Avg Closing Trade (90 D):	$14.52M
Avg Closing Volume:	126.34K

News

Jul 29, 2026 @ 2:55 PM NASDAQ: CELC Investigation: Kessler Topaz Meltzer ... Source: Kessler Topaz Meltzer & Check, Llp

Jul 21, 2026 @ 8:58 PM CELCUITY ALERT: Bragar Eagel & Squire, P.C. is Inv... Source: Bragar Eagel & Squire, P.C.

Jul 14, 2026 @ 8:53 PM Celcuity Announces FDA Approval of REVTORPYKâ„Â... Source: Celcuity Inc.

Jun 4, 2026 @ 2:13 AM Celcuity Inc. Announces Pricing of Upsized Public ... Source: Na

Apr 27, 2026 @ 10:18 PM Why Celcuity Stock Popped on Monday Source: Eric Volkman

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-4.31	$-1.44	$-.97
Diluted EPS	$-4.31	$-1.44	$-.97
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-226.48M	$-78.86M	$-52.84M
Operating Income / Loss	$-208.68M	$-66.12M	$-50.51M
Cost of Revenue
Net Cash Flow	$135.7M	$36.86M	$-20.51M
PE Ratio